...
首页> 外文期刊>International journal of molecular medicine >Differential gene expression profiles in spontaneously hypertensive rats induced by administration of enalapril and nifedipine
【24h】

Differential gene expression profiles in spontaneously hypertensive rats induced by administration of enalapril and nifedipine

机译:依那普利和硝苯地平致自发性高血压大鼠的差异基因表达谱

获取原文
获取原文并翻译 | 示例

摘要

Enalapril and nifedipine are used as antihypertensive drugs; however, the therapeutic target molecules regulated by enalapril and nifedipine have yet to be fully identified. The aim of this study was to identify novel target genes that are specifically regulated by enalapril and nifedipine in tissues from spontaneously hypertensive rats (SHR) using DNA microarray analysis. We found that administration of SHR with enalapril and nifedipine differentially regulated 33 genes involved in the pathogenesis of cardiovascular diseases. Furthermore, we identified 16 genes that have not previously been implicated in cardiovascular diseases, including interleukin-24 (IL-24). Among them, exogenous administration of IL-24 attenuated the expression of vascular inflammation and hypertension-related genes induced by H2O2 treatment in mouse vascular smooth muscle (MOVAS) cells. This study provides valuable information for the development of novel antihypertensive drugs. In addition, the genes identified may be of use as biomarkers and therapeutic targets for cardiovascular diseases, including hypertension.
机译:依那普利和硝苯地平被用作降压药。然而,依那普利和硝苯地平调节的治疗靶分子尚未完全确定。这项研究的目的是使用DNA微阵列分析技术鉴定自发性高血压大鼠(SHR)组织中依那普利和硝苯地平特异性调节的新型靶基因。我们发现与依那普利和硝苯地平一起使用SHR可以差异调节33种参与心血管疾病发病机制的基因。此外,我们鉴定了16种以前未参与心血管疾病的基因,包括白介素24(IL-24)。其中,IL-24的外源给药减弱了H2O2处理在小鼠血管平滑肌(MOVAS)细胞中诱导的血管炎症和高血压相关基因的表达。该研究为新型降压药的开发提供了有价值的信息。另外,所鉴定的基因可以用作心血管疾病包括高血压的生物标志物和治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号